The Brain Tumor Center at Dana-Farber/Boston Children's Cancer and Blood Disorders Center features two world-class treatment programs offering patients deep expertise and advanced therapies for specific conditions. Each program features an authority in his/her area of expertise as well as teams of subspecialists and nurses with focused training and years of proven experience.
The strength of our programs comes in part from the research performed by researchers like Susan Chi, MD, who is looking for innovative ways to treat malignant infant tumors such as high risk medulloblastoma.
Patients with medulloblastoma come to Dana-Farber/Boston Children's Medulloblastoma Program from around the globe to get treated by brain tumor specialists and pediatric subspecialists with specific and advanced expertise in treating these rare but invasive tumors.
The Glioma Program at Dana-Farber/Boston Children's is the largest of it's kind in the world.
A genetic test can explain why a child or young adult developed cancer and can help predict whether he is at risk for other conditions.